PROCEPT BioRobotics (PRCT) Revenue (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Revenue data on file, last reported at $83.1 million in Q1 2026.

• On a quarterly basis, Revenue rose 20.2% year-over-year to $83.1 million in Q1 2026; TTM through Mar 2026 was $322.0 million, a 29.26% increase from a year earlier, with the FY2025 full-year figure at $308.1 million, up 37.22% from the prior year.
• Revenue for Q1 2026 stood at $83.1 million, up from $76.4 million in the prior quarter.
• Over the last five years, Revenue for PRCT reached as high as $83.3 million in Q3 2025 and fell as low as $14.2 million in Q1 2022.
• Historically, Revenue has averaged $48.6 million across 5 years, with a median of $44.5 million in 2024.
• Across the five-year window, Revenue jumped 134.76% in 2022 and grew 11.94% in 2025, its largest moves.
• Year by year, Revenue stood at $23.8 million in 2022, then surged by 83.29% to $43.6 million in 2023, then jumped by 56.57% to $68.2 million in 2024, then rose by 11.94% to $76.4 million in 2025, then advanced by 8.84% to $83.1 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $83.1 million in Q1 2026, $76.4 million in Q4 2025, and $83.3 million in Q3 2025.